drugset / Trial / NCT07070882

Oral Steroid Taper After Total Knee Arthroplasty

NCT07070882

Phase 1 Active not recruiting 116 enrolled Columbia University
RandomizedParallel-groupSingle-blindPrevention

Summary

This study aims to evaluate the effectiveness of an oral methylprednisolone taper in reducing postoperative pain, opioid consumption, and nausea following primary total knee arthroplasty (TKA).

Timeline

Start
2025-06-20
Primary completion
2025-12-01
Completion
2027-06-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified 4 mg Oral

Indications